"Great nations are built by visionaries who turn challenges into opportunities." Had the privilege of meeting Shri Piyush Goyal Ji, India’s Minister of Commerce & Industry and Member of Parliament (Lok Sabha). His leadership is driving India’s economic transformation, strengthening global trade, and fostering innovation. Coming from the U.S., I see India’s rise with fresh eyes—a nation fueled by entrepreneurship, technology, and ambition. In his speech, he touched upon several topics, including healthcare, trade, and economic growth, reinforcing one truth: India is not just preparing for the future—it is creating it. Excited to learn, collaborate, and contribute to this incredible journey! #IndiaRising #Leadership #PiyushGoel #Minister #MemberofParliament #Innovation #GlobalTrade #PiyushGoyal #EconomicGrowth #FutureIsNow American Association for Precision Medicine (AAPM) WISE World Investors & Entrepreneurs Society Agility Pharmaceuticals #sustainability #AtificialIntelligence #AI #News
关于我们
Agility is an artificial intelligence (AI) driven pharmaceutical company committed to revolutionizing drug discovery through BigData, Robotics and AI.
- 网站
-
https://www.dhirubhai.net/in/agilitypharma
Agility Pharmaceuticals的外部链接
- 所属行业
- 制药业
- 规模
- 11-50 人
- 总部
- Belmont,CA
- 类型
- 私人持股
- 领域
- Drug Development
地点
-
主要
640 Masonic Way, PO Box 150
US,CA,Belmont,94002
动态
-
"A long and healthy life isn’t built in a day, but it is built every day." I often reflect on a simple but profound truth: We all have a power to shape our destiny - one choice, one habit, one day at a time.. Nowhere is this more evident than in the fight against cancer. February—National Cancer Prevention Month and World Cancer Day—reminds us that prevention is not just a strategy; it is a way of life. As someone deeply invested in longevity and precision medicine, I see cancer prevention as more than just reducing risk—it’s about extending healthspan, not just lifespan. Cancer is not an overnight occurrence; it is the result of years of cellular changes, lifestyle choices, and environmental exposures. But just as cancer develops over time, so can resilience. We can rewrite our health trajectory, one choice at a time. Here’s how: ?? Live with movement. A sedentary life invites disease. Daily exercise, even a simple walk, can cut cancer risk significantly. ?? Eat like your future depends on it. Because it does. A diet rich in greens, antioxidants, and whole foods nourishes cells and reduces inflammation—the root of many cancers. ?? Respect your body’s limits. Smoking, excessive alcohol, and processed foods may seem insignificant today, but they shape your health tomorrow. Choose wisely. ?? Invest in early detection. Routine screenings don’t just diagnose cancer—they save lives. A simple test today can mean years of life tomorrow. ?? Heal from within. Chronic stress is a silent carcinogen. Meditation, mindfulness, and strong social connections nurture not just the mind, but the immune system. In my work at the intersection of healthcare, innovation, and longevity, I have seen breakthroughs in cancer detection and treatment. But prevention remains our greatest weapon—one that is in our hands today. This February, I invite you to take a step, make a choice, and embrace a lifestyle that honors your future self. Cancer prevention is not just about avoiding disease—it’s about building a life of vitality, purpose, and longevity. Share this post as a reminder that every small choice matters—for ourselves, our loved ones, and a healthier future for all. #NationalCancerPreventionMonth #WorldCancerDay #CancerPrevention #Longevity #Healthspan American Association for Precision Medicine (AAPM) Agility Pharmaceuticals #PrecisionMedicine #PreventionMatters
-
-
Excited to have been part of the closing keynote discussion at the OCT West Coast conference in San Francisco, CA, where we delved into the transformative role of sustainable drug development in the future of clinical trials. Alongside my esteemed colleagues, Sarah Hamirani of AstraZeneca, Joshua Cox of Eli Lilly and Company, Yuyi Shen, Abcuro, Inc and Jasmina Jankicevic, of RAPT Therapeutics, we engaged in a thought-provoking discussion that underscores the potential of sustainability to drive better outcomes for both patients and clinical sites. I am sharing some key insights and takeaways in the article below, Titled Sustainable Drug Development—the Way Forward. #SustainableDrugDevelopment #AIinHealthcare #ClinicalTrials #PrecisionMedicine #FutureOfHealth #InnovationWithPurpose #AI #ArtificialIntelligence #Leadership #OCTWest #OCTWest2025 American Association for Precision Medicine (AAPM) Agility Pharmaceuticals #sustainability #SDG3 United Nations
-
"Sustainable drug development isn’t an option—it’s the only way forward." Honored to be a part of the closing #keynote panel of the OCT West Conference in San Francisco, CA. A week ago, I sat with some of the brightest minds in drug development from leading companies such as Eli Lilly and Company, Abcuro, Inc., Agility Pharmaceuticals, RAPT Therapeutics, and AstraZeneca. The conversation was electric—how do we lay the framework for sustainable drug development, accelerate clinical trials, and ensure life-saving therapies reach patients faster? Then, several questions started flowing: ?? Can we develop drugs faster without compromising safety? ?? Can we innovate responsibly, ensuring medicines remain affordable and accessible? ?? Can we balance ‘right now’ vs. ‘the right way’ in clinical trials? These questions have stayed with me, shaping my approach to drug development—not as a race to the finish line but as a commitment to sustainability, equity, and long-term impact. This is why I am truly excited to join my fellow panelists in the closing keynote session on sustainable drug development, where we’ll explore: ? Breaking the cycle of high-cost innovation to create truly accessible medicines ? Why ‘just because we can’ doesn’t always mean we should ? How AI and real-world evidence (RWE) are transforming drug discovery ? The ethical dilemma of speed vs. sustainability in clinical trials We are at a pivotal moment in healthcare. Will we chase short-term wins or invest in a future where life-saving therapies are available to all? The choice is ours. Let’s shape a future where innovation serves humanity—not just the market. Join me in this conversation. Let’s build solutions that last. ???? #SustainableDrugDevelopment #AIinHealthcare #ClinicalTrials #PrecisionMedicine #FutureOfHealth #InnovationWithPurpose #AI #ArtificialIntelligence #Leadership #OCTWest #OCTWest2025 American Association for Precision Medicine (AAPM) Agility Pharmaceuticals #sustainability #SDG3 United Nations
-
-
Excited to Share Our Latest Article on Healthcare AI! AI is shaping the future of healthcare, but the real transformation lies in how we use it. Our latest article explores the challenges and opportunities of Healthcare-Specific LLMs, diving into the critical role of real-world data, domain expertise, and responsible AI development. The article includes insights from Jyothi Devakumar, Healthy Vignettes, yours truly Dr. Prasun Mishra, Agility Pharmaceuticals and American Association for Precision Medicine (AAPM) Vinod Subramanian, MedAdvisor Solutions US, and Vijay Karunamurthy, Scale AI From precision medicine to clinical decision support, the potential is immense—but only if we build AI systems that are ethical, trustworthy, and collaborative. Let’s continue the conversation! How do you see AI impacting healthcare in the next decade? #AIinHealthcare #FutureOfMedicine #EthicalAI #Innovation
-
"Together, we’re not just imagining the future of healthcare—we’re building it, one breakthrough at a time." ?? Thrilled to have presented on the Role of AI in Healthcare from Discovery to Delivery at a HealthTech Conference during JPM 2025 week, where the energy around AI in healthcare was nothing short of transformative. From discovery to delivery, AI is unlocking new possibilities, driving precision, and ensuring compassion remains at the core of innovation. Let’s continue to collaborate, innovate, and shape the future of healthcare—together. #JPM2025 #AIInHealthcare #Innovation #FutureOfMedicine #Collaboration #HealthcareInnovation #EmpathyInInnovation #Sustainability #PrecisionMedicine #Collaboration American Association for Precision Medicine (AAPM) WISE World Investors & Entrepreneurs Society Agility Pharmaceuticals #News
-
-
"I have a dream, so pure, so bright, A world where health is a human right. No lives cut far too short, Just love and laughter, our true support. With hope and science, hand in hand, We’ll heal the hurt, across the land. Together, strong, we’ll see the day, Where illness fades and joy will stay." Today, in the spirit of MLK Day, I share my dream of a world where health, happiness, and healing are within everyone’s reach—a world where no one suffers the pain of preventable loss. What’s your dream? Please share—it’s through our shared dreams and collective efforts that we can truly build a brighter future. #MLKDay #HealthForAll #Innovation #Equity American Association for Precision Medicine (AAPM) WISE World Investors & Entrepreneurs Society Agility Pharmaceuticals #MartinLutherKing #MLKDay2025 Image credit: schiller[dot]edu, MLKDay2025
-
-
? "Behind every breakthrough is a dreamer who refused to give up." ? Attending the UCSF Innovation Showcase and Reception during JPM 2025 was a powerful reminder of the transformative work happening at the intersection of health care, science, and innovation. From pioneering startups to visionary leaders, the event highlighted UCSF’s commitment to advancing solutions that truly impact lives. I am proud to support this incredible community as an Advisor to UCSF Innovation Ventures and Catalyst Program and a former Board Member of UCSF Health Hub. Here’s to the dreamers turning ideas into breakthroughs and shaping the future of health care! #UCSFInnovation #JPM2025 #HealthcareInnovation #PrecisionMedicine
-
-
"When we innovate with empathy, we pave the way for a future where health is a gift everyone can enjoy." Day 3 of the 43rd Annual J.P. Morgan Healthcare Conference was a testament to how empathy can drive progress in healthcare. The conversations were not just about numbers and products but about the human lives they touch. Every breakthrough shared today was fueled by the desire to make health accessible, equitable, and transformative for all. Pfizer’s expansion of its mRNA vaccine platform is a powerful reminder of innovation's role in protecting our future. But it’s not just about technology; it’s about using that technology to safeguard the lives of millions. Amgen’s sustainability pledge to reach net-zero emissions by 2045 is a brilliant example of how the healthcare industry is thinking beyond treatments. It's about preserving the world in which we live and ensuring that future generations can thrive in a healthy environment. On the oncology front, AstraZeneca’s advancements with antibody-drug conjugates are breaking down barriers in cancer care, offering patients new hope in their journey. Moderna’s focus on personalized cancer vaccines shows us how medicine can become as unique as each individual, bringing us closer to treatments that fit each person’s specific needs. And in a world where technology continues to evolve, the collaboration between Oracle and Amazon Web Services on clinical trials is an example of how AI and cloud computing are accelerating drug development to bring life-saving treatments to patients faster. Day 3 reminded us that every innovation is an opportunity to serve humanity and to create a world where healthcare is not just a privilege but a universal gift. Together, we are shaping a future where health is a shared responsibility and a common benefit. What inspired you most today? Let’s continue to innovate with empathy for a healthier tomorrow. #JPM2025 #HealthcareInnovation #EmpathyInInnovation #Sustainability #PrecisionMedicine #Collaboration American Association for Precision Medicine (AAPM) WISE World Investors & Entrepreneurs Society Agility Pharmaceuticals #News
-
-
"Bold moves and big visions—Day 2 proves the future of healthcare is brighter than ever." Thrilled to witness the incredible progress the healthcare industry has made collectively. Day 2 of the 43rd Annual J.P. Morgan Healthcare Conference was not just about announcements—it was about redefining possibilities and embracing the bold vision needed to transform lives. Merck’s $25 billion diversification plan signals a strategic pivot, ensuring a robust future as KEYTRUDA? (pembrolizumab) HCP’s patent winds down. Meanwhile, Novartis’s $8 billion projection for KISQALI HCP fuels hope for breast cancer patients, proving that determination and innovation go hand in hand. On the tech frontier, NVIDIA’s partnerships with industry leaders like IQVIA and Mayo Clinic are reshaping what’s possible with AI, showing us that the future of precision medicine lies in collaboration. Even amidst challenges, like Biogen doubling down on Alzheimer’s or Eli Lilly and Company addressing Mounjaro? (tirzepatide) HCP fluctuations, the spirit of resilience shines. These aren’t just business moves—they’re declarations of unwavering commitment to better health for all. As I reflect on today, I am inspired. Each announcement is more than a milestone—it’s a promise to patients and a reminder that the best days of healthcare are still ahead. What inspired you most today? Let’s share ideas and shape the future together. #PrecisionMedicine #Oncology #PrecisionHealth #JPM2025 #JPMORGAN #AAPM #AAPMHealth #AAPM_Health American Association for Precision Medicine (AAPM) Agility Pharmaceuticals WISE World Investors & Entrepreneurs Society #JPMorgan2025 #HealthcareInnovation #Collaboration #SanFrancisco #Collaboration #SanFrancisco
-